MCL
Clinical trials for MCL explained in plain language.
Never miss a new study
Get alerted when new MCL trials appear
Sign up with your email to follow new studies for MCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope for patients with aggressive lymphoma that Won't quit
Disease control OngoingThis trial is testing a new drug called epcoritamab in people with B-cell lymphoma that has come back or stopped responding to standard treatments. The main goals are to find a safe and effective dose, understand the side effects, and see how well the drug works to control the ca…
Matched conditions: MCL
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Apr 02, 2026 00:26 UTC
-
New drug duo tested for aggressive blood cancer
Disease control OngoingThis early-stage study is testing whether combining two drugs, glofitamab and lenalidomide, is a safe and feasible treatment for adults with mantle cell lymphoma that has come back or stopped responding to other therapies. It is specifically for people whose cancer progressed aft…
Matched conditions: MCL
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC